Opinion: An Existing Drug to Assess In Vivo for Potential Adjunctive Therapy of Ebola Virus Disease and Post-Ebola Syndrome
Main Authors: | Katherine Hendricks, Meredith Gilman Parrado, John Bradley |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.01691/full |
Similar Items
-
Biomarker Correlates of Survival in Pediatric Patients with Ebola Virus Disease
by: Anita K. McElroy, et al.
Published: (2014-10-01) -
Feasibility of Xpert Ebola Assay in Médecins Sans Frontières Ebola Program, Guinea
by: Rafael Van den Bergh, et al.
Published: (2016-02-01) -
Post-Ebola Syndrome, Sierra Leone
by: Janet T. Scott, et al.
Published: (2016-04-01) -
Ethicizing the Ebola Epidemic
by: Louisa Howard
Published: (2014-10-01) -
The Boundaries of Treating Ebola
by: Dallas Ducar
Published: (2014-08-01)